227 related articles for article (PubMed ID: 31402250)
1. Body Mass Index and Unenhanced CT as a Predictor of Hepatic Steatosis in Potential Liver Donors.
Adalı G; Bozkurt B; Ceyhan Ö; Server S; Doğusoy GB; Yüzer Y; Tokat Y
Transplant Proc; 2019 Sep; 51(7):2373-2378. PubMed ID: 31402250
[TBL] [Abstract][Full Text] [Related]
2. Preoperative Evaluation of Liver Parenchyma of Potential Donors in Living Donor Liver Transplantation.
Novruzov N; Bayramov N; Mammadov E
Transplant Proc; 2019 Sep; 51(7):2379-2382. PubMed ID: 31474295
[TBL] [Abstract][Full Text] [Related]
3. Macrovesicular steatosis in living related liver donors: correlation of biopsy findings with CT liver attenuation index and body mass index.
Jehangir M; Nazir R; Jang A; Rana A; Rafique S; Dar FS
Clin Transplant; 2016 Sep; 30(9):1016-20. PubMed ID: 27291347
[TBL] [Abstract][Full Text] [Related]
4. Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings.
Limanond P; Raman SS; Lassman C; Sayre J; Ghobrial RM; Busuttil RW; Saab S; Lu DS
Radiology; 2004 Jan; 230(1):276-80. PubMed ID: 14695401
[TBL] [Abstract][Full Text] [Related]
5. Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors: comparison of visual grading with liver attenuation index.
Lee SW; Park SH; Kim KW; Choi EK; Shin YM; Kim PN; Lee KH; Yu ES; Hwang S; Lee SG
Radiology; 2007 Aug; 244(2):479-85. PubMed ID: 17641368
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive evaluation of graft steatosis in living donor liver transplantation.
Iwasaki M; Takada Y; Hayashi M; Minamiguchi S; Haga H; Maetani Y; Fujii K; Kiuchi T; Tanaka K
Transplantation; 2004 Nov; 78(10):1501-5. PubMed ID: 15599315
[TBL] [Abstract][Full Text] [Related]
7. Virtual noncontrast images derived from dual-energy CT for assessment of hepatic steatosis in living liver donors.
Kang HJ; Lee DH; Park SJ; Han JK
Eur J Radiol; 2021 Jun; 139():109687. PubMed ID: 33836335
[TBL] [Abstract][Full Text] [Related]
8. Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment.
Park SH; Kim PN; Kim KW; Lee SW; Yoon SE; Park SW; Ha HK; Lee MG; Hwang S; Lee SG; Yu ES; Cho EY
Radiology; 2006 Apr; 239(1):105-12. PubMed ID: 16484355
[TBL] [Abstract][Full Text] [Related]
9. Comparison of CT methods for determining graft steatosis in living donor liver transplantation.
Şeker M; Erol C; Sevmiş Ş; Saka B; Durur Karakaya A
Abdom Radiol (NY); 2019 Jul; 44(7):2418-2429. PubMed ID: 30937504
[TBL] [Abstract][Full Text] [Related]
10. Predictive Value of Unenhanced Computerized Tomography for Detecting Hepatosteatosis in Living Liver Donors.
Kuzu UB; Gökcan H; Suna N; Özdemir M; Yıldız H; Kaçar S; Turhan N; Ökten S; Bostancı B; Akdoğan M
Transplant Proc; 2015; 47(6):1854-9. PubMed ID: 26293063
[TBL] [Abstract][Full Text] [Related]
11. Is Unenhanced Computed Tomography Reliable in the Assessment of Macrovesicular Steatosis in Living Liver Donors?
Haberal KM; Turnaoğlu H; Haberal Reyhan AN
Exp Clin Transplant; 2019 Dec; 17(6):749-752. PubMed ID: 31666000
[TBL] [Abstract][Full Text] [Related]
12. Hypoattenuation in unenhanced CT reflects histological graft dysfunction and predicts 1-year mortality after living donor liver transplantation.
Cho JY; Suh KS; Lee HW; Cho EH; Yang SH; Cho YB; Yi NJ; Kim MA; Jang JJ; Lee KU
Liver Transpl; 2006 Sep; 12(9):1403-11. PubMed ID: 16724340
[TBL] [Abstract][Full Text] [Related]
13. CT indices for the diagnosis of hepatic steatosis using non-enhanced CT images: development and validation of diagnostic cut-off values in a large cohort with pathological reference standard.
Byun J; Lee SS; Sung YS; Shin Y; Yun J; Kim HS; Yu ES; Lee SG; Lee MG
Eur Radiol; 2019 Aug; 29(8):4427-4435. PubMed ID: 30569183
[TBL] [Abstract][Full Text] [Related]
14. Predicting Hepatic Steatosis in Living Liver Donors via Noninvasive Methods.
Kim JM; Ha SY; Joh JW; Sinn DH; Jeong WK; Choi GS; Gwak GY; Kwon CHD; Kim YK; Paik YH; Lee JH; Lee WJ; Lee SK; Park CK
Medicine (Baltimore); 2016 Feb; 95(7):e2718. PubMed ID: 26886612
[TBL] [Abstract][Full Text] [Related]
15. Effects of donor steatosis on liver biochemistry and significance of body mass index in predicting steatosis.
Siriwardana RC; Chan SC; Chok KS; Lo CM; Fan ST
HPB (Oxford); 2012 Sep; 14(9):619-24. PubMed ID: 22882199
[TBL] [Abstract][Full Text] [Related]
16. The Utility of Noninvasive Scoring Systems for Prediction of Hepatic Steatosis in Liver Transplantation Donor Candidates.
Sahin T; Arikan BT; Serin A; Emek E; Bozkurt B; Server S; Dibekoglu C; Tokat Y
Transplant Proc; 2019 Sep; 51(7):2383-2386. PubMed ID: 31402248
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive assessment of macrovesicular liver steatosis in cadaveric donors based on computed tomography liver-to-spleen attenuation ratio.
Rogier J; Roullet S; Cornélis F; Biais M; Quinart A; Revel P; Bioulac-Sage P; Le Bail B
Liver Transpl; 2015 May; 21(5):690-5. PubMed ID: 25761371
[TBL] [Abstract][Full Text] [Related]
18. Clinical implications of preoperative and intraoperative liver biopsies for evaluating donor steatosis in living related liver transplantation.
Jun MJ; Shim JH; Kim SY; Seo N; Kim KM; Lim YS; Lee HC; Yu E; Lee SG
Liver Transpl; 2014 Apr; 20(4):437-45. PubMed ID: 24478019
[TBL] [Abstract][Full Text] [Related]
19. Body mass index as a predictor of hepatic steatosis in living liver donors.
Rinella ME; Alonso E; Rao S; Whitington P; Fryer J; Abecassis M; Superina R; Flamm SL; Blei AT
Liver Transpl; 2001 May; 7(5):409-14. PubMed ID: 11349260
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive estimation of hepatic steatosis in living liver donors: usefulness of visceral fat area measurement.
Yamashiki N; Sugawara Y; Tamura S; Kaneko J; Matsui Y; Togashi J; Ohki T; Yoshida H; Omata M; Makuuchi M; Kokudo N
Transplantation; 2009 Aug; 88(4):575-81. PubMed ID: 19696642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
